US91307C1027 - Common Stock
Let's have a look at what is happening on the US markets after the closing bell on Tuesday. Below you can find the top gainers and losers in today's after hours session.
Although several companies have seen their valuations blossom, you can still find bargain stocks if you know where to look.
Learn about these undervalued NASDAQ stocks teeming with the potential to bounce back and show great returns for investors this year.
These three companies represent the world of biotech stocks and offer a unique blend of high risk and potentially high reward.
Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.
These biotech stocks offer exciting and disruptive solutions with the potential to expand to market caps worth trillions.
In the volatile world of biotech stocks, keeping an eye on the news is critical. Here are three companies to look out for.
MannKind (MNKD) sells a 1% royalty in Tyvaso DPI net sales to Sagard Healthcare for up to $200M, receiving an upfront payment of $150M.
Liquidia stock jumps 36% after winning a patent dispute against United Therapeutics, causing the latter stock to drop 4%.
United Therapeutics (UTHR) has extended the licensing deal with Eli Lilly (LLY) for Adcirca (tadalafil) through December 31, 2026. The deal covering the U.S. ma
Discover healthcare stocks with remarkable potential for growth and "unicorn" status in the ever-evolving world of healthcare investments.
Hindenburg raised red flags for flying car stocks after releasing a short report on EH stock. Here's what investors should watch.
EH stock is falling back to earth after Hindenburg Research issued a short report on the electric vertical take-off and landing (eVTOL) firm.